Kestra Advisory Services’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,500
Closed -$39K 2266
2022
Q3
$39K Hold
12,500
﹤0.01% 2041
2022
Q2
$41K Hold
12,500
﹤0.01% 2052
2022
Q1
$64K Buy
+12,500
New +$64K ﹤0.01% 1953